Atlas Trials

Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed by Surgery

Clinical trial NCT01835145 · COMPLETED

Trial details

NCT number
NCT01835145
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Recurrent Uveal MelanomaStage III Uveal Melanoma AJCC v7Stage IIIA Uveal Melanoma AJCC v7Stage IIIB Uveal Melanoma AJCC v7Stage IIIC Uveal Melanoma AJCC v7Stage IV Uveal Melanoma AJCC v7
Start date
2013-07-31
Primary completion
2016-10-21
Enrollment
47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.